{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T20:07:51Z","timestamp":1763842071535,"version":"3.45.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"PIDS Summer Research Scholars Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite widespread vaccination, the United States has seen a stark increase in pertussis cases over the past year. Disease profiles vary across age groups, with infants at the greatest risk. The development of next generation pertussis vaccines will involve updated antigenic content, novel adjuvants, and live-attenuated constructs, potentially leveraging controlled human infection models of pertussis.<\/jats:p>","DOI":"10.1093\/jpids\/piaf098","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:22:58Z","timestamp":1761830578000},"source":"Crossref","is-referenced-by-count":0,"title":["Pertussis: Modern Approaches to an Ancient Adversary"],"prefix":"10.1093","volume":"14","author":[{"given":"C Buddy","family":"Creech","sequence":"first","affiliation":[{"name":"Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center , Nashville, TN ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dakota","family":"Musgrave","sequence":"additional","affiliation":[{"name":"Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center , Nashville, TN ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"author":"CDC","key":"2025112215061429300_ref1"},{"year":"2024","author":"CDC","key":"2025112215061429300_ref2"},{"key":"2025112215061429300_ref3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/jama.1995.03520370086042","article-title":"Pertussis infection in adults with persistent cough","volume":"273","author":"Wright","year":"1995","journal-title":"JAMA."},{"key":"2025112215061429300_ref4","doi-asserted-by":"publisher","first-page":"2208514","DOI":"10.1080\/21645515.2023.2208514","article-title":"Estimating the pertussis burden in adolescents and adults in the United States between 2007 and 2019","volume":"19","author":"Macina","year":"2023","journal-title":"Hum Vaccin Immunother"},{"author":"Prevention CfDCa","key":"2025112215061429300_ref5"},{"key":"2025112215061429300_ref6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: Overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics."},{"key":"2025112215061429300_ref7"},{"key":"2025112215061429300_ref8","doi-asserted-by":"publisher","first-page":"e20153326","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap effectiveness in adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics."},{"key":"2025112215061429300_ref9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1542\/peds.2014-3358","article-title":"Tdap vaccine effectiveness in adolescents during the 2012 Washington state pertussis epidemic","volume":"135","author":"Acosta","year":"2015","journal-title":"Pediatrics."},{"key":"2025112215061429300_ref10","first-page":"572","article-title":"On the doctrine of original antigenic sin","volume":"104","author":"Thomas","year":"1960","journal-title":"Proc Am Philos Soc"},{"key":"2025112215061429300_ref11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.2012.6364","article-title":"Number and order of whole cell pertussis vaccines in infancy and disease protection","volume":"308","author":"Sheridan","year":"2012","journal-title":"JAMA."},{"key":"2025112215061429300_ref12","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1542\/peds.2013-3181","article-title":"Duration of protection after first dose of acellular pertussis vaccine in infants","volume":"133","author":"Quinn","year":"2014","journal-title":"Pediatrics."},{"key":"2025112215061429300_ref13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/mi.2012.117","article-title":"Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates","volume":"6","author":"Warfel","year":"2013","journal-title":"Mucosal Immunol"},{"key":"2025112215061429300_ref14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025112215061429300_ref15","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1093\/infdis\/jit493","article-title":"Nonhuman primate and human challenge models of pertussis","volume":"209","author":"Merkel","year":"2014","journal-title":"J Infect Dis"},{"key":"2025112215061429300_ref16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compouds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"2025112215061429300_ref17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"Lambrecht","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"2025112215061429300_ref18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/hv.22755","article-title":"A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis","volume":"9","author":"Asokanathan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"2025112215061429300_ref19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41541-024-00990-1","article-title":"A novel outer membrane vesicle adjuvant improves vaccine protection against Bordetella pertussis","volume":"9","author":"Galeas-Pena","year":"2024","journal-title":"NPJ Vaccines"},{"key":"2025112215061429300_ref20","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1128\/IAI.73.11.7317-7323.2005","article-title":"Influence of CR3 (CD11b\/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils","volume":"73","author":"Mobberley-Schuman","year":"2005","journal-title":"Infect Immun"},{"key":"2025112215061429300_ref21","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1128\/IAI.01104-06","article-title":"Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model","volume":"74","author":"Cheung","year":"2006","journal-title":"Infect Immun"},{"key":"2025112215061429300_ref22","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1016\/j.vaccine.2022.09.075","article-title":"Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults","volume":"40","author":"Buddy Creech","year":"2022","journal-title":"Vaccine."},{"key":"2025112215061429300_ref23","doi-asserted-by":"publisher","first-page":"168322","DOI":"10.1016\/j.jmb.2023.168322","article-title":"Benefits of combining molecular biology and controlled human infection model methodologies in advancing vaccine development","volume":"435","author":"ElSherif","year":"2023","journal-title":"J Mol Biol"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piaf098\/65042536\/piaf098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/11\/piaf098\/65042536\/piaf098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/11\/piaf098\/65042536\/piaf098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T20:06:18Z","timestamp":1763841978000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/doi\/10.1093\/jpids\/piaf098\/8306908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piaf098","relation":{},"ISSN":["2048-7207"],"issn-type":[{"type":"electronic","value":"2048-7207"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,30]]},"article-number":"piaf098"}}